News | Cardio-oncology | February 06, 2018

Cell Phone Radiation Exposure Linked to Tumor Activity in Male Rats

High-radiofrequency exposure from cell phones causes tumors in around nerves in rat hearts

Cell phone emissions cause cardiac tumors in males rats.

February 6, 2018 — High exposure to radiofrequency radiation (RFR) in rodents resulted in tumors in tissues surrounding nerves in the hearts of male rats, but not female rats or any mice, according to draft studies from the National Toxicology Program (NTP). The exposure levels used in the studies were equal to and higher than the highest level permitted for local tissue exposure in cell phone emissions today. Cell phones typically emit lower levels of RFR than the maximum level allowed. NTP’s draft conclusions were released as two technical reports, one for rat studies and one for mouse studies. NTP will hold an external expert review of its complete findings from these rodent studies March 26-28.

The incidence of tumors, called malignant schwannomas, that were observed in the heart increased in male rats as they were exposed to increasing levels of RFR beyond the allowable cell phone emissions. Researchers also noted increases in an unusual pattern of cardiomyopathy in exposed male and female rats. Overall, there was little indication of health problems in mice related to RFR.

The reports also point out statistically significant increases in the number of rats and mice with tumors found in other organs at one or more of the exposure levels studied, including the brain, prostate gland, pituitary gland, adrenal gland, liver and pancreas. However, the researchers determined that these were equivocal findings, meaning it was unclear if any of these tumor increases were related to RFR.

“The levels and duration of exposure to RFR were much greater than what people experience with even the highest level of cell phone use, and exposed the rodents’ whole bodies. So, these findings should not be directly extrapolated to human cell phone usage,” said John Bucher, Ph.D., NTP senior scientist. “We note, however, that the tumors we saw in these studies are similar to tumors previously reported in some studies of frequent cell phone users.”

To conduct the studies, NTP built special chambers that exposed rats and mice to different levels of RFR for up to two years. Exposure levels ranged from 1.5 to 6 watts per kilogram (W/kg) in rats, and 2.5 to 10 W/kg in mice. The low power level for rats was equal to the highest level permitted for local tissue exposures to cell phone emissions today. The animals were exposed for 10-minute on, 10-minute off increments, totaling just over 9 hours each day. The studies used 2G and 3G frequencies and modulations still used in voice calls and texting in the United States. More recent 4G, 4G-LTE, and 5G networks for streaming video and downloading attachments use different cell phone signal frequencies and modulations than NTP used in these studies.

The NTP studies also looked for a range of noncancer health effects in rats and mice, including changes in body weight, evidence of tissue damage from RFR-generated heating and genetic damage. Researchers saw lower body weights among newborn rats and their mothers, especially when exposed to high levels of RFR during pregnancy and lactation. Yet, these animals grew to normal size.

“These studies were complex and technically challenging, but they provide the most comprehensive assessment, to date, of health effects in rats and mice from exposure to RFR,” said Bucher. “Cell phone technologies are constantly changing, and these findings provide valuable information to help guide future studies of cell phone safety.”

The U.S. Food and Drug Administration (FDA) nominated cell phone radiofrequency radiation for study by NTP because of widespread use of cell phones. FDA and the Federal Communications Commission are jointly responsible for regulating wireless communication devices.

“One part of the Food and Drug Administration’s mission is to ensure the safety of electronic products that emit radiation, like televisions and cell phones. These types of products are part of Americans’ daily life and we take our duty to protect consumers with the utmost gravity,” said Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health.

He noted, “In the meantime, I want to underscore that based on our ongoing evaluation of this issue and taking into account all available scientific evidence we have received, we have not found sufficient evidence that there are adverse health effects in humans caused by exposures at or under the current radiofrequency energy exposure limits. Even with frequent daily use by the vast majority of adults, we have not seen an increase in events like brain tumors. Based on this current information, we believe the current safety limits for cell phones are acceptable for protecting the public health.

Shuren added that the conclusions still require careful discussion and that the FDA will be participating in the peer review of this study in March.

For more information: www.ntp.niehs.nih.gov

 


Related Content

News | Cardio-oncology

Feb. 9, 2026 —The International Cardio-Oncology Society has awarded University Hospitals in Cleveland, Ohio, with a ...

Home March 19, 2026
Home
News | Cardio-oncology

June 19, 2024 — Modern therapies have extended the lives of many cancer patients; however, survivors often live with ...

Home June 19, 2024
Home
News | Cardio-oncology

February 1, 2023 — The International Cardio-Oncology Society has awarded University Hospitals (UH) Harrington Heart & ...

Home February 01, 2023
Home
News | Cardio-oncology

May 23, 2022 — New data from a study of more than 100 million hospitalizations using machine learning augmentation was ...

Home May 23, 2022
Home
News | Cardio-oncology

February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMCC) ...

Home February 25, 2021
Home
News | Cardio-oncology

July 29, 2019 — Cancer patients taking cholesterol-lowering statin medication following radiation therapy of the chest ...

Home July 29, 2019
Home
Videos | Cardio-oncology

Magid Awadalla, MBBS, is an advanced cardiac imaging research fellow at Massachusetts General Hospital. He has been ...

Home March 22, 2019
Home
News | Cardio-oncology

March 13, 2019 — An imaging procedure commonly performed before starting cancer treatment can provide valuable clues ...

Home March 13, 2019
Home
News | Cardio-oncology

January 28, 2019 — The American College of Cardiology host the third Advancing the Cardiovascular Care of the Oncology ...

Home January 28, 2019
Home
News | Cardio-oncology

January 3, 2019 — Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage ...

Home January 03, 2019
Home
Subscribe Now